首药控股股价涨5%，国泰基金旗下1只基金重仓，持有2.62万股浮盈赚取5.13万元

Group 1 - The core point of the news is that Shouyao Holdings has seen a 5% increase in stock price, reaching 41.13 CNY per share, with a total market capitalization of 6.117 billion CNY [1] - Shouyao Holdings, established on April 19, 2016, specializes in the research and development of small molecule anti-tumor drugs, with 100% of its revenue coming from technology development and services [1] - The trading volume for Shouyao Holdings was 43.6067 million CNY, with a turnover rate of 1.68% [1] Group 2 - From the perspective of fund holdings, Guotai Fund has a significant position in Shouyao Holdings, with its Guotai Innovation Medical Mixed Fund A holding 26,200 shares, accounting for 4.77% of the fund's net value [2] - The Guotai Innovation Medical Mixed Fund A, established on April 18, 2023, has a current scale of 17.7778 million CNY and has achieved a year-to-date return of 45.74% [2] - The fund manager, Qiu Xiaoxu, has a tenure of 3 years and 78 days, with the fund's total assets amounting to 676 million CNY [2]